THE ANAPHYLATOXINS C3A AND C5A ARE VASODILATORS IN THE CANINE CORONARY VASCULATURE INVITRO AND INVIVO

被引:52
作者
SCHUMACHER, WA
FANTONE, JC
KUNKEL, SE
WEBB, RC
LUCCHESI, BR
机构
[1] UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,ANN ARBOR,MI 48109
[2] UNIV MICHIGAN,SCH MED,DEPT PATHOL,ANN ARBOR,MI 48109
[3] UNIV MICHIGAN,SCH MED,DEPT PHYSIOL,ANN ARBOR,MI 48109
来源
AGENTS AND ACTIONS | 1991年 / 34卷 / 3-4期
关键词
D O I
10.1007/BF01988727
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The effect of complement fragments on coronary blood flow in vivo and the contraction of coronary arteries in vitro was determined. In pentobarbital anesthetized dogs, intraarterial bolus injection of C3a and C5a, zymosan-activated serum and methylcholine in the coronary vascular bed caused transient and dose-dependent increases in coronary blood flow. Similar increases were obtained with 25-mu-g of C3a (104 +/- 13%, n = 5) and 0.1-mu-g of methylcholine (102 +/- 4%, n = 3). Smaller increases in blood flow were elicited by 25-mu-g of C5a (41 +/- 18%, n = 4) and 0.2 ml of zymosan-activated serum (48 +/- 5%, n = 4). None of these responses were associated with significant changes in left ventricular contractile force measured with a strain gauge, arterial blood pressure, and heart rate. C3a dilated the coronary vascular bed in conscious dogs with an activity equal to or greater than that observed in anesthetized dogs. Isolated canine coronary arteries that were precontracted with serotonin relaxed in response to C3a, whether or not the endothelium was intact. Overall these data suggest that physiologically high doses of anaphylactic complement fragments vasodilate the canine coronary circulation.
引用
收藏
页码:345 / 349
页数:5
相关论文
共 18 条
[1]   ACTIVATION OF THE COMPLEMENT-SYSTEM BY RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR [J].
BENNETT, WR ;
YAWN, DH ;
MIGLIORE, PJ ;
YOUNG, JB ;
PRATT, CM ;
RAIZNER, AE ;
ROBERTS, R ;
BOLLI, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (03) :627-632
[2]  
BJORK J, 1985, J IMMUNOL, V134, P1115
[3]   EFFECT OF THE THROMBOXANE RECEPTOR ANTAGONIST SQ-29,548 ON MYOCARDIAL INFARCT SIZE IN DOGS [J].
GROVER, GJ ;
SCHUMACHER, WA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 11 (01) :29-35
[4]  
HACHFELD U, 1985, P NATL ACAD SCI USA, V82, P886
[5]   PHLOGISTIC ROLE OF C3 LEUKOTACTIC FRAGMENTS IN MYOCARDIAL INFARCTS OF RATS [J].
HILL, JH ;
WARD, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1971, 133 (04) :885-&
[6]  
Hugli T E, 1978, Adv Immunol, V26, P1, DOI 10.1016/S0065-2776(08)60228-X
[7]   EFFECTS OF THE C5A ANAPHYLATOXIN AND ITS RELATIONSHIP TO CYCLO-OXYGENASE METABOLITES IN RABBIT VASCULAR STRIPS [J].
HUGLI, TE ;
MARCEAU, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 84 (03) :725-733
[8]  
HYMAN AL, 1978, AM REV RESPIR DIS, V117, P111
[9]   THROMBOXANE-A2 AND PEPTIDOLEUKOTRIENES CONTRIBUTE TO THE MYOCARDIAL-ISCHEMIA AND CONTRACTILE DYSFUNCTION IN RESPONSE TO INTRACORONARY INFUSION OF COMPLEMENT-C5A IN PIGS [J].
ITO, BR ;
ROTH, DM ;
ENGLER, RL .
CIRCULATION RESEARCH, 1990, 66 (03) :596-607
[10]  
KUNKEL SL, 1983, J IMMUNOL METHODS, V62, P41